Dr. Alex C Spyropoulos received his medical degree from the University of Pennsylvania School of Medicine in Philadelphia in 1992. Dr. Spyropoulos was the Founder and former Medical Director of the Clinical Thrombosis Center in Albuquerque, New Mexico. He is presently the first System Medical Director of the Anticoagulation and Clinical Thrombosis Service line of the large multihospital Northwell Health System in New York. He is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell, a Professor at the Institute of Health System Science of the Feinstein Institutes for Medical Research, and more recently, a Professor at the Elmezzi Graduate School of Molecular Medicine. He is co-chair of the Council on Leadership of Thrombosis at Northwell Health System. Dr. Spyropoulos has been the Principal or Co-Principal Investigator of multiple global clinical trials in thrombosis, and his research work has included the pioneering of outpatient-based treatment of venous thromboembolic (VTE) disease, perioperative heparin “bridging” or lack thereof for patients on chronic anticoagulation, extended thromboprophylaxis of medical inpatients, clinical use of novel oral anticoagulants, development of the VTE risk score in medical inpatients (IMPROVE), and assessing optimal thromboprophylaxis strategies during the COVID-19 pandemic. He has co-chaired multiple international antithrombotic guidelines. He has published over 300 peer-reviewed manuscripts.